Need for improvement of cardiovascular health: a clustering method to identify cardiovascular health profiles.

"Conflict of interest: Jessica Soyer, Amélie Gabet, Clémence Grave, Clara Piffaretti, Charlotte Verdot, Benoit Salanave, Valérie Deschamps, Sandrine Fosse-Edorh, Laura Carcaillon-Bentata and Valérie Olié have nothing to disclose."

"Funding The Esteban survey is part of the French National Nutrition and Health Plan (PNNS), the French National Health Environment Plan (PNSE) and the National Biosafety launch. It was funded by public subsidies from the French Ministry of Solidarities and Health and the Ministry of Ecological and Solidarity Transition. The funding sources had no involvement in the study design, the data collection, analysis and interpretation, the writing of the report or the decision to submit the article for publication. Conflict of interest: Jessica Soyer, Amélie Gabet, Clémence Grave, Clara Piffaretti, Charlotte Verdot, Benoit Salanave, Valérie Deschamps, Sandrine Fosse-Edorh, Laura Carcaillon-Bentata and Valérie Olié have nothing to disclose."

"The study was performed among participants of the Esteban survey, a French cross-sectional study conducted between April 2014 and March 2016. The survey design was a complex three-stage stratified random sample. The first stage was a random selection of communes (primary units), the second stage was a random selection of households (secondary units) by telephone sampling and the third stage was a random selection of a single individual from the household. Details on the conduct of the survey are available in the previously published protocol study. Recruitment took place among non-institutionalized adults aged 18–74 years living in France. This survey was carried out in three main stages: (1) face-to-face interviews and self-administrated questionnaires, (2) a food consumption survey and (3) a clinical examination. Participant data were linked to the French National Health Data System (SNDS, Système National des Données de Santé) to identify the participants’ pharmaceutical consumption in the year preceding the clinical examination. The Esteban study was registered with the French National Agency for Medicines and Health Products Safety (No.2012-A00456-34) and was approved by the Ethical Committee (CPP) and French Data Protection Authority (CNIL). All participants provided written consent."